Works matching IS 10837159 AND DT 2018 AND VI 23 AND IP 6


Results: 23
    1
    2

    Can We Hang Our Hats on One Percent?

    Published in:
    Oncologist, 2018, v. 23, n. 6, p. 642, doi. 10.1634/theoncologist.2018-0153
    By:
    • LeVasseur, Nathalie;
    • Gelmon, Karen A.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.

    Published in:
    Oncologist, 2018, v. 23, n. 6, p. 658, doi. 10.1634/theoncologist.2017-0325
    By:
    • Tolcher, Anthony;
    • Flaherty, Keith;
    • Shapiro, Geoffrey I.;
    • Berlin, Jordan;
    • Witzig, Thomas;
    • Habermann, Thomas;
    • Bullock, Andrea;
    • Rock, Edwin;
    • Elekes, Agnes;
    • Lin, Chester;
    • Kostic, Dusan;
    • Ohi, Naoto;
    • Rasco, Drew;
    • Papadopoulos, Kyriakos P.;
    • Patnaik, Amita;
    • Smith, Lon;
    • Cote, Gregory M.
    Publication type:
    Article
    14
    15
    16
    17
    18

    Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer.

    Published in:
    Oncologist, 2018, v. 23, n. 6, p. 654, doi. 10.1634/theoncologist.2017-0690
    By:
    • von Pawel, Joachim;
    • Spigel, David R.;
    • Ervin, Thomas;
    • Losonczy, György;
    • Barlesi, Fabrice;
    • Juhász, Erzsébet;
    • Anderson, Maria;
    • McCall, Bruce;
    • Wakshull, Eric;
    • Hegde, Priti;
    • Ye, Weilan;
    • Chen, Daniel;
    • Chang, Ilsung;
    • Rhee, Ina;
    • Reck, Martin
    Publication type:
    Article
    19
    20
    21
    22
    23